Ensoma Appoints Jon Garen as Chief Corporate Development and Business Officer
Key Highlights Jon Garen joins Ensoma as Chief Corporate Development and Business Officer Garen’s experience spans genomic medicines, oncology,…
Browsing Tag
Dunad Therapeutics
2 posts
Entact Bio Appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer
Key Highlights Entact Bio appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer. Dr. Tommasi brings 30 years of drug…